Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Compugen Ltd’s stock clocked out at $2.06, down -2.37% from its previous closing price of $2.11. In other words, the price has decreased by -$2.37 from its previous closing price. On the day, 0.92 million shares were traded. CGEN stock price reached its highest trading level at $2.13 during the session, while it also had its lowest trading level at $1.99.
Ratios:
To gain a deeper understanding of CGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.74 and its Current Ratio is at 4.74. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $4.
On August 05, 2022, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEN now has a Market Capitalization of 192682832 and an Enterprise Value of 101775832. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.70 while its Price-to-Book (P/B) ratio in mrq is 3.83. Its current Enterprise Value per Revenue stands at 4.596 whereas that against EBITDA is -5.266.
Stock Price History:
The Beta on a monthly basis for CGEN is 2.51, which has changed by 0.19075143 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, CGEN has reached a high of $2.66, while it has fallen to a 52-week low of $1.13. The 50-Day Moving Average of the stock is 35.21%, while the 200-Day Moving Average is calculated to be 25.11%.
Shares Statistics:
It appears that CGEN traded 328.65K shares on average per day over the past three months and 758960 shares per day over the past ten days. A total of 93.54M shares are outstanding, with a floating share count of 91.55M. Insiders hold about 2.12% of the company’s shares, while institutions hold 16.47% stake in the company. Shares short for CGEN as of 1759190400 were 908369 with a Short Ratio of 2.76, compared to 1756425600 on 941735. Therefore, it implies a Short% of Shares Outstanding of 908369 and a Short% of Float of 1.0.
Earnings Estimates
. The current rating of Compugen Ltd (CGEN) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.07 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.3 and -$0.38 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.37, with 2.0 analysts recommending between -$0.3 and -$0.44.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for CGEN’s current fiscal year. The highest revenue estimate was $8.36M, while the lowest revenue estimate was $3.5M, resulting in an average revenue estimate of $6.45M. In the same quarter a year ago, actual revenue was $27.86M
